Fodosine forodesine hydrochloride regulatory update

FDA granted Fodosine forodesine Fast Track designation for relapsed or refractory T cell leukemia. The purine nucleoside phosphorylase (PNP) inhibitor is in Phase IIa testing to treat T cell leukemia...